What Is Tomo?
2017 will be the tipping point for clinics in the higher and lower half of diagnostic imaging. In only five years since it gained clearance from the FDA, 35% of U.S. clinics are already using 3D mammography, or tomosynthesis (tomo). At the end of 2017, over half of all U.S. clinics will be operating with tomo. Tomo is now the standard of care in mammography. Nearly all clinics are projected to use tomo in 2020.
Women are more informed than ever. Women are starting to demand this revolutionary new screening and diagnostic breast imaging tool to improve the early detection of breast cancer. With breast cancer being the most diagnosed cancer in women, it affects one in every eight women in the U.S. Women whose breast cancer is detected at an early stage have a 93% or more survival rate in the first five years.
Tomosynthesis has ascended the throne to become the new standard in breast imaging. Especially for women with dense breasts. Additional diagnostic images is reduced thanks to this new technology. This means there are fewer unnecessary callbacks and reduced patient anxiety. This new technology also reduces your overall patient expense. In other words, tomo is a great improvement on the previously relied upon traditional mammography.
How Tomo is Better Than Traditional Mammography
Traditional mammograms are transforming. Using tomo makes it easier for doctors to catch breast cancer early. In fact, it helps catch more cancers compared to 2D mammography. In comparison to digital 2D mammograms, tomo reveals 35% more cancerous tissue. With less discomfort to the patient at that. It provides a clearer view of the cancer size than on a traditional mammogram. Tomo helps to reduce the chances of doctors seeing a false positive. Additionally, reads of the results are easier and more reliable. Above all else, patients have peace of mind knowing the best technologies are at work in keeping them healthy.
Tomosynthesis is more affordable than you think. If you provide this groundbreaking service, tomo can increase monthly revenue. By the end of 2017, over 50% of mammography providers will be offering tomo. It’s time to start thinking about making the transition.